-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Biogen Inc. quarterly Current Federal Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Biogen Inc. Current Federal Tax Expense (Benefit) for the quarter ending December 31, 2023 was $378M, a 45.6% decline year-over-year.
- Biogen Inc. Current Federal Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $378M.
Current Federal Tax Expense (Benefit), Trailing 12 Months (USD)
Current Federal Tax Expense (Benefit), Quarterly Data (USD)